Back to the main directory
EarningsReview / Equity
- Espresso | Galp | Buy | Q2 trading statement (=) by Kepler Cheuvreux
- Preview of H1 Results and Strategic Update by BNP Paribas
- (08 – 12 July 2019) by Oddo BHF
- Espresso | ABN AMRO | Buy | Q2 preview: NII over EUR1.6bn, clean cost -0.9% YOY, cost of risk of 20bps by Kepler Cheuvreux
- Howzat?! by BNP Paribas
- Citycon (Buy, TP: EUR10.50) - More stable than reflected in P/NAV by DnB Markets
- Mowi (Sell, TP: NOK170.00) - Strong trading update by DnB Markets
- Elisa (Sell, TP: EUR36.00) - Peak valuation despite no growth by DnB Markets
- Pandox (Hold, TP: SEK200.00) - Rally reduces upside potential by DnB Markets
- Aker BP (Buy, TP: NOK320.00) - Q2: more than we asked for by DnB Markets
- Coloplast (Sell, TP: DKK700.00) - Not valued for uncertainties by DnB Markets
- Alligator Bioscience (Buy, TP: SEK42.00) - Encouraging ADC-1013 data by DnB Markets
- Sparebank1 SR-Bank Minor model adjustments by DnB Markets
- Sparebank 1 Østlandet Minor model adjustments by DnB Markets
- Keppel REIT (KREIT SP) - 2Q19: Decent performance despite high base by UOB
- Key markets in good health by BNP Paribas
- Espresso | Novartis | Buy | Q2 preview by Kepler Cheuvreux
- 360 Report | Sampo | Buy | Dividend machine keeps on humming by Kepler Cheuvreux
- Let''s not get carried away by BNP Paribas
- INVEST SECURITIES - COVIVIO HOTELS (NEUTRE, OC 25€ vs 26€) : Un nouveau semestre mitigé by Invest Securities
- FY20 margin pressured by lower fee growth and fixed cost headwinds by BNP Paribas
- Two Key Debates by BNP Paribas
- Keppel DC REIT (KDCREIT SP) by HSBC
- Highlighting the importance of MandA by BNP Paribas
- Aker Solutions (Buy, TP: NOK60.00) - Particularly good time to step in by DnB Markets